The latest from BioStock
» PHI on how TO 3 proceeds will be used
» Ultimovacs updates timeline for INITIUM study
» Newly appointed CMO sees opportunities in Stayble Therapeutics
» Article about CombiGene's epilepsy project published in Gene Therapy
» Increased bids for Sensidose
Read BioStock's newsletter for v.16 here.
Se Prostatype Genomics Pitch on Tuesday, May 2, 08:45 AM.
Watch the latest episode of in the banner below.
Morning news
Idogen for discussions regarding reverse acquisition. The company intends to add a decision item at the Annual General Meeting on June 8 for possible liquidation. Read more.
Redsense Medical announces that they held a 510(k) Pre-Submission meeting with the FDA. Read more.
Proby continues market expansion and receives new approval in Thailand. Read more.
Lumito presenting at the Tucson Symposium. Read more.
Getinge strengthens its presence in India. Read more.
Interim reports:
AcuCort Biotage Carbiotix Corline Biomedical Dicot Doxa Episurf Medical Iconovo (correction) Orion Pihlajalinna Senzime
Annual reports:
Alzinova Brain+ Bio-Works Technologies Cantargia Cyxone Iconovo Lumito Kancera PCI Biotech Holding Raysearch Laboratories Vistin Pharma
Invitation to presentations:
ArcticZymes Technologies Gentian Diagnostics Q-line
Invitations:
Biovica International Calliditas Therapeutics Genetic Analysis OncoZenge Orthoma Pila Pharma Targovax 2cureX
Changes in votes and equity:
Communiqués:
BioInvent International BioPorto Biotage Doxa Egetis Therapeutics Medicover Virogates Vitrolife
News since Thursday lunch
Dicot announced that their toxicology program was completed with good results. Read more.
Alzinova has announced a change in the management team. Read more.
WntResearch has withdrawn the proposal to approve a related party transaction at the Annual General Meeting. Read more.
Carbiotix decided on a rights issue of units. Read more.
Hansa Biopharma and Genethon has entered into cooperation in the development of imlifidase as pretreatment for gene therapy in Crigler-Najjar syndrome for patients with antibodies to AAV. Read more.
Bioretec has raised 10 million euros through directed new issues. Read more.
Qlife announced the outcome of the issue. Read more.
CS MEDICA gave an update on the collaboration with RongShi Medica. Read more.
Devotion has won this year's Swecare Export Awards. Read more.
BioGaia announced that they are launching dietary supplements for women before and during pregnancy. Read more.
Intellego announced preliminary figures for the first quarter of 2023. Read more.
This morning's price development
Winner: Gabather 14,8%, Calmark 13,1%, Idogen 9,4%, Enzymatica 9%, Prolight Diagnostics 7%
Förlorare: Carbiotix -27%, Odinwell -12,6%, Prostatype Genomics -9,4%, Alligator Bioscience -9,1%, Raytelligence -9%
Index: OMXS30 2, -255%, Healthcare -0,69%